/
/
/

Vivo Bio Tech Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Mar 2018
₹14 Cr₹14 Cr₹14 Cr₹13 Cr₹13 Cr₹12 Cr₹12 Cr₹12 Cr₹10 Cr₹12 Cr₹13 Cr₹9 Cr₹12 Cr₹15 Cr₹14 Cr₹13 Cr₹11 Cr₹15 Cr₹13 Cr₹10 Cr₹13 Cr₹16 Cr₹12 Cr₹15 Cr₹9 Cr₹14 Cr₹14 Cr₹14 Cr₹13 Cr₹14 Cr₹14 Cr₹14 Cr₹12 Cr
₹6 L₹3 L₹14 L₹13 L₹14 L₹15 L₹80,000₹5 Cr₹1 L₹90,000₹3 L₹0₹0₹2 L₹90,000₹60,000₹10,000-₹15 L₹0₹3 L₹22 L₹8 L₹0₹0₹0₹2 L₹0₹3 L₹0₹0₹0₹0₹60,000
₹14 Cr₹14 Cr₹14 Cr₹13 Cr₹13 Cr₹12 Cr₹12 Cr₹17 Cr₹10 Cr₹12 Cr₹13 Cr₹9 Cr₹12 Cr₹15 Cr₹14 Cr₹13 Cr₹11 Cr₹15 Cr₹13 Cr₹10 Cr₹13 Cr₹16 Cr₹12 Cr₹15 Cr₹9 Cr₹14 Cr₹14 Cr₹14 Cr₹13 Cr₹14 Cr₹14 Cr₹14 Cr₹12 Cr
₹13 Cr₹12 Cr₹11 Cr₹10 Cr₹10 Cr₹10 Cr₹9 Cr₹9 Cr₹8 Cr₹9 Cr₹9 Cr₹7 Cr₹9 Cr₹10 Cr₹11 Cr₹10 Cr₹9 Cr₹16 Cr₹9 Cr₹8 Cr₹10 Cr₹14 Cr₹8 Cr₹10 Cr₹8 Cr₹14 Cr₹12 Cr₹11 Cr₹11 Cr₹12 Cr₹13 Cr₹11 Cr₹11 Cr
₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹6 Cr₹10 Cr₹4 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr₹7 Cr₹5 Cr₹5 Cr₹5 Cr₹1 Cr₹6 Cr₹3 Cr₹6 Cr₹4 Cr₹5 Cr₹6 Cr₹3 Cr₹1 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr
₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹87 L₹1 Cr₹1 Cr₹86 L₹1 Cr₹54 L₹1 Cr₹70 L₹79 L₹68 L₹75 L₹88 L₹64 L₹66 L₹69 L₹62 L
₹34 L₹25 L₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹6 Cr₹22 L₹1 Cr₹2 Cr₹46 L₹25 L₹3 Cr₹55 L₹51 L₹69 L-₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr₹3 Cr₹4 Cr₹92 L-₹73 L₹2 Cr₹2 Cr₹2 Cr-₹3 Cr₹1 Cr₹2 Cr₹1 Cr
₹19 L-₹5 Cr₹1 Cr₹87 L₹1 Cr₹1 Cr₹82 L₹5 Cr₹17 L₹74 L₹1 Cr₹33 L₹14 L₹2 Cr₹15 L₹12 L₹32 L-₹69 L₹1 Cr₹28 L₹1 Cr₹30 L₹2 Cr₹2 Cr₹98 L-₹41 L₹1 Cr₹2 Cr₹1 Cr-₹3 Cr₹1 Cr₹2 Cr₹80 L

Share Price Live Stats

Open (₹)14.44
Volume (₹)1,800.00
High (₹)14.44
Upper Circuit16.22
Low (₹)13.43
Lower Circuit10.82
Prev Close13.52
52W High (₹)35.76
Price13.88
52W Low (₹)12.20

Share Market Cap & Key Ratios Overview

M.Cap (₹)30.00 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.74
Price to Book0.51
Book Value41.13
EPS (TTM)-1.29
Face Value10.00
ROE (%)-2.11

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
VIVOBIOT-BNSE
LTP
1W Low
1W High
Market cap (₹)
1776-2.25 (-0.13%)
1720.80
1809.65
4,25,150Cr
10036+321 (3.30%)
9866.35
10080.20
2,66,265Cr
4730+94.85 (2.05%)
4555
4730
1,76,301Cr
2306.1-85.9 (-3.59%)
2252.50
2442
1,25,352Cr
1190-54 (-4.34%)
1182.05
1266.15
1,23,591Cr
1372+21.8 (1.61%)
1337.30
1390.70
1,14,351Cr
1400.1+20.1 (1.46%)
1364.75
1400.60
1,12,474Cr
2533.15+44.4 (1.78%)
2457.35
2539
1,02,315Cr
1701.1+23.3 (1.39%)
1656.90
1724.50
97,757Cr
2015+6 (0.30%)
1989.10
2061.55
92,007Cr
13.88+0.05 (0.36%)
13.43
14.94
30Cr

Key Highlights of Vivo Bio Tech Ltd’s P&L

In 2025-03-31, Vivo Bio Tech Ltd reported total revenue of ₹51.48Cr, compared with ₹45.49Cr in 2024-03-31, reflecting Vivo Bio Tech Ltd turnover.

Depreciation was ₹9.02Cr and finance costs were ₹7.55Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹8.79Cr in 2025-03-31 as compared to ₹4.06Cr in 2024-03-31.

Net Profit (PAT) was ₹7.28Cr in 2025-03-31 compared with ₹2.53Cr in 2024-03-31.

Earnings per share (EPS) were ₹4.24 in 2025-03-31, compared with ₹1.70 in 2024-03-31.